Synsam AB Cash Flow Conversion Efficiency
Synsam AB cash flow conversion efficiency. Based on the latest financial reports, Synsam AB (SYNSAM) has a cash flow conversion efficiency ratio of 0.144x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr374.00 Million ≈ $40.25 Million USD) by net assets (Skr2.61 Billion ≈ $280.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Synsam AB (2018–2025)
Cash flow conversion efficiency of Synsam AB from 2018 to 2025. This chart illustrates how Synsam AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Synsam AB stock price today for real-time trading data and today's change.
Synsam AB Cash Flow Conversion Ratio Explained
Synsam AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Synsam AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Synsam AB ranked by their cash flow conversion efficiency. Also see Synsam AB (SYNSAM) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangsu Seagull Cooling Tower
SHG:603269
|
0.235x |
|
MasterBrand Inc.
NYSE:MBC
|
0.065x |
|
Janux Therapeutics Inc
NASDAQ:JANX
|
-0.013x |
|
Wuhan Fingu Electronic Technology Co Ltd
SHE:002194
|
0.036x |
|
Beijing Hotgen Biotech Co Ltd
SHG:688068
|
0.001x |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
0.018x |
|
Jiangsu Gian Technology Co Ltd
SHE:300709
|
0.215x |
|
Hunan Er Kang Pharmaceutical
SHE:300267
|
0.040x |
Annual Cash Flow Conversion Efficiency for Synsam AB (2018–2025)
The table below shows the annual cash flow conversion efficiency of Synsam AB from 2018 to 2025. Review Synsam AB free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr2.44 Billion ≈ $262.04 Million |
Skr1.27 Billion ≈ $136.35 Million |
0.520x | +42.49% |
| 2024-12-31 | Skr2.56 Billion ≈ $274.96 Million |
Skr933.00 Million ≈ $100.41 Million |
0.365x | -20.11% |
| 2023-12-31 | Skr2.52 Billion ≈ $270.76 Million |
Skr1.15 Billion ≈ $123.76 Million |
0.457x | +71.17% |
| 2022-12-31 | Skr2.58 Billion ≈ $278.08 Million |
Skr690.00 Million ≈ $74.26 Million |
0.267x | -32.45% |
| 2021-12-31 | Skr2.48 Billion ≈ $266.78 Million |
Skr980.00 Million ≈ $105.46 Million |
0.395x | +169.28% |
| 2020-12-31 | Skr-1.57 Billion ≈ $-169.45 Million |
Skr898.50 Million ≈ $96.69 Million |
-0.571x | +2.58% |
| 2019-12-31 | Skr-1.37 Billion ≈ $-147.63 Million |
Skr803.50 Million ≈ $86.47 Million |
-0.586x | -92.99% |
| 2018-12-31 | Skr-1.20 Billion ≈ $-128.78 Million |
Skr363.20 Million ≈ $39.09 Million |
-0.304x | -- |
About Synsam AB
Synsam AB (publ), together with its subsidiaries, operates in the optical retail and eye health sector in the Nordic Region. The company offers lenses, frames, sunglasses, sports spectacles, contact lenses, eye care accessories, and hearing aids. It also provides eye health services, hearing tests, lifestyle subscriptions, contact lens subscriptions, personal style advice services, and eye examin… Read more